Christine Reilley is business development director of Healthcare for the Technology Advancement and Business Development (TABD) unit of the American Society of Mechanical Engineers (ASME), based in New York City. As director, she leads the ASME Alliance of Advanced Biomedical Engineering (AABME), which focuses on creating and growing the Society’s portfolio of programs, products, and services in this area. Christine had previously served as program manager in the ASME Emerging Technologies unit, developing content and conferences in areas focusing on bioengineering, nanotechnology, thermofluids, and materials. Previously, she spent more than 10 years in ASME Publishing as an editor, overseeing the production of codes and standards from manuscript to final bound and digital product. Previously, she was a senior editor for Research and Education Association (REA), an educational publishing company, and also served as a technical editor and science writer for UC San Diego’s Biomedical Informatics Research Network (BIRN) and the National Center for Microscopy and Imaging Research (NCMIR). In addition, Christine was a report editor for XenoBiotic Laboratories (XBL), a contract research organization specializing in pharmaceutical, environmental, and metabolism chemistry. At XBL, she coordinated the production and editing of technical reports for submission to corporate sponsors and regulatory bodies. She earned an MS in Biomedical Engineering with a concentration in Tissue Engineering and Biomaterials from New Jersey Institute of Technology (NJIT). She received a BA in Journalism and Mass Media with a minor in Biological Sciences from Rutgers University, Douglass College.